Who
Mark A. Morais
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Fortrea Holdings.
In numbers
- Trades disclosed
- 118
- Buys
- 0
- Sells
- 15
- Bought
- $0
- Sold
- $862K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 20 Jun 2023
- Last trade
- 9 Sep 2026
- Last filed
- 10 Sep 2026
Companies traded
Activity over time
1 Feb 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Sep 2026filed 10 Sep 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $53K3,149 at $16.85 | filing |
| 9 Sep 2026filed 10 Sep 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $53K3,149 at $16.85 | filing |
| 8 Sep 2026filed 10 Sep 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —7,157 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —7,157 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —7,157 at $0.00 | filing |
| 8 Sep 2026filed 10 Sep 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —7,157 at $0.00 | filing |
| 19 Aug 2026filed 19 Aug 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $89K4,892 at $18.19 | filing |
| 19 Aug 2026filed 19 Aug 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $89K4,892 at $18.19 | filing |
| 18 Aug 2026filed 19 Aug 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —11,313 at $0.00 | filing |
| 18 Aug 2026filed 19 Aug 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —11,313 at $0.00 | filing |
| 18 Aug 2026filed 19 Aug 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —11,313 at $0.00 | filing |
| 18 Aug 2026filed 19 Aug 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —11,313 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $79K4,674 at $16.82 | filing |
| 10 Jun 2026filed 12 Jun 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $79K4,674 at $16.82 | filing |
| 2 Jun 2026filed 3 Jun 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $75K4,866 at $15.49 | filing |
| 2 Jun 2026filed 3 Jun 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $75K4,866 at $15.49 | filing |
| 1 Jun 2026filed 3 Jun 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —11,006 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —11,006 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —11,006 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —11,006 at $0.00 | filing |
News
Critical Review: Champions Oncology (NASDAQ:CSBR) and Fortrea (NASDAQ:FTRE)FTRE · dailypolitical.com · 18 Oct 2026Reviewing MindWalk (NASDAQ:HYFT) & Fortrea (NASDAQ:FTRE)FTRE · tickerreport.com · 12 Oct 2026
0 headlines in the last 90 days name Mark A. Morais; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.